Brief Report

Treatment of Parkinson's disease in Spain

  1. Francisco Grandas MD, PhD1,*,
  2. Jaime Kulisevsky MD2

Article first published online: 9 SEP 2002

DOI: 10.1002/mds.10294

Issue

Movement Disorders

Movement Disorders

Volume 18, Issue 1, pages 87–89, January 2003

Additional Information

How to Cite

Grandas, F. and Kulisevsky, J. (2003), Treatment of Parkinson's disease in Spain. Mov. Disord., 18: 87–89. doi: 10.1002/mds.10294

Author Information

  1. 1

    Servicio de Neurología, Hospital General Universitario Gregorio Marañón, Madrid, Spain

  2. 2

    Servicio de Neurología. Hospital de la Santa Creu i San Pau, Barcelona, Spain

*Servicio de Neurología, Hospital General Universitario Gregorio Marañón, C/ Doctor Esquerdo 46, 28007 Madrid, Spain

Publication History

  1. Issue published online: 31 DEC 2002
  2. Article first published online: 9 SEP 2002
  3. Manuscript Accepted: 19 JUN 2002
  4. Manuscript Revised: 2 MAY 2002
  5. Manuscript Received: 9 OCT 2001

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (46K)

Keywords:

  • Parkinson's disease;
  • treatment;
  • antiparkinsonian drugs;
  • Spain

Abstract

To assess the patterns of drug use in Parkinson's disease in Spain, information about the clinical characteristics and current treatment of 1,803 parkinsonian patients was obtained from a nationwide survey, involving 241 physicians with practice based on the different assistance levels of the Spanish National Healthcare System. Approximately 90% of the patients were treated with levodopa, regardless of the characteristics of their physicians, but the use of the other available antiparkinsonian treatments was highly influenced by the medical specialty and interest in movement disorders of the prescribing doctors. © 2002 Movement Disorder Society

View Full Article (HTML) Get PDF (46K)